| abstract |
COMPOSITIONS AND DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF DIMETHHYL SULFOXIDE AS A PHARMACEUTICAL ARE DESCRIBED, WHEREIN THE DIMETHYL SULFOXIDE CONCENTRAAATION IS BETWEEN ABOUT 10% AND ABOUT 90% AND WHEREIN DILUENTS, TOGETHER WITH DIMETHYL SULFOXIDE-SOLUBLE LIPOIDAAL THICKENING AGENTS, WATER-DISPERSIBLE THICKENING AGENTS AND EMULSION-BASE THICKENING AGENTS, ARE INCLUDED IN SUCH COMPOSITIONS. SUPPOSITORIES CONTAINING DIMETHYL SULFOXIDE (DMSO) ARE ALSO DESCRIBED. LIQUID FORMULATIONS FOR TOPICAL APPLICATION INCLUDING AT LEAST 10% DMSO AND AND AAQUEOUS DILUENT IN SPRAY CONTAINERS ARE ALSO PROVIDED. |